This list is based on the watchlists of people on Stock Events who follow VBIO. It's not an investment recommendation.
This list is an analysis based on recent market events. It's not an investment recommendation.
Valion Bio Inc is a late-stage biopharmaceutical company developing biologics that activate innate immune pathways for cytoprotection and immune modulation. Its main candidate, Entolimod, is a TLR5 agonist and also advances Entolasta, a next-generation TLR5 agonist, and targets the neutropenia oncology supportive care market.
Show more...
FAQ
What is Valion Bio stock price today?▼
The current price of VBIO is $2.80 USD — it has decreased by -10.26% in the past 24 hours. Watch Valion Bio stock price performance more closely on the chart.
What is Valion Bio stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Valion Bio stocks are traded under the ticker VBIO.
What is Valion Bio market cap?▼
Today Valion Bio has the market capitalization of 2.49M
When is the next Valion Bio earnings date?▼
Valion Bio is going to release the next earnings report on November 13, 2026.
What is Valion Bio revenue for the last year?▼
Valion Bio revenue for the last year amounts to 0 USD.
What is Valion Bio net income for the last year?▼
VBIO net income for the last year is -8.88M USD.
How many employees does Valion Bio have?▼
As of September 04, 2026, the company has 52 employees.
In which sector is Valion Bio located?▼
Valion Bio operates in the Health & Wellness sector.
When did Valion Bio complete a stock split?▼
The last stock split for Valion Bio was on August 31, 2026 with a ratio of 1:25.
Where is Valion Bio headquartered?▼
Valion Bio is headquartered in SAN ANTONIO, United States.